Study Review – Five-year efficacy and safety of ofatumumab in people with relapsing forms of multiple sclerosis

As part of our series focussing on research on new medicines in Australia, we have added a study review of the use of ofatumumab in people living with relapsing forms of multiple sclerosis.

This publication focuses on the open-label ALITHIOS extension trial which evaluated the long-term effectiveness and safety of ofatumumab. It also provides commentary from Clinical Associate Professor Todd Hardy, Senior Staff Specialist Neurologist at Concord Hospital, and co-director of the MS Clinic at the Brain & Mind Centre.